Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein properties.
Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, Tanaka R, Kubota N, Matsumoto I, Ishii A, Tamaoka A, Shimbo A, Mori M, Morio T, Kishi T, Miyamae T, Tanboon J, Inoue M, Nishino I, Fujimoto M, Nomura T, Okiyama N.
Ichimura Y, et al. Among authors: miyamae t.
J Dermatol. 2022 Apr;49(4):441-447. doi: 10.1111/1346-8138.16295. Epub 2021 Dec 29.
J Dermatol. 2022.
PMID: 34967032